These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 4330662)

  • 41. Ethambutol in re-treatment of pulmonary tuberculosis.
    Am Rev Respir Dis; 1968 Nov; 98(5):825-36. PubMed ID: 4300827
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical and bacteriological results with Myambutol.
    Goldman S; Brzaković N; Muzikravić T
    Antibiot Chemother; 1970; 16():239-56. PubMed ID: 4332036
    [No Abstract]   [Full Text] [Related]  

  • 43. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
    Trébucq A; Rieder HL
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
    [No Abstract]   [Full Text] [Related]  

  • 44. Ethambutol treatment of tuberculosis in a controlled trial.
    Segarra FO; Lorian V; Sherman DS
    Scand J Respir Dis; 1968; 49(3):202-6. PubMed ID: 4980226
    [No Abstract]   [Full Text] [Related]  

  • 45. [Proceedings: Preliminary results of a 2-phase therapy with rifampicin, ethambutol and a third drug in chronic polyresistant tuberculoses].
    Neumeyer D; Anschel R; Eule H; Fichtner K; Ganguin HG; Pickroth G
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):135-8. PubMed ID: 4491710
    [No Abstract]   [Full Text] [Related]  

  • 46. Ethambytol in the retreatment of pulmonary tuberculosis. United States Public Health Service cooperative trial.
    Steininger WJ
    Bull Int Union Tuberc; 1968 Dec; 41():181-2. PubMed ID: 4303861
    [No Abstract]   [Full Text] [Related]  

  • 47. A clinical trial of ethambutol in the retreatment of pulmonary tuberculosis--mostly on ambulatory basis.
    Yang SP; Luh KT; Wu MH
    Taiwan Yi Xue Hui Za Zhi; 1968 Aug; 67(8):348-58. PubMed ID: 5259188
    [No Abstract]   [Full Text] [Related]  

  • 48. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council Investigation.
    Tubercle; 1974 Mar; 55(1):1-27. PubMed ID: 4620294
    [No Abstract]   [Full Text] [Related]  

  • 49. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 50. [Results of 6-month and 9-month treatments with rifampin, isoniazid and ethambutol in cases of newly detected tuberculosis].
    Szymanski A; Gaik A
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(3):181-3. PubMed ID: 6273991
    [No Abstract]   [Full Text] [Related]  

  • 51. [Pulmonary Mycobacterium fortuitum infection with multiple nodular shadows in a healthy man].
    Inoue T; Tanaka E; Sakuramoto M; Maeda Y; Maniwa K; Taguchi Y
    Kekkaku; 2004 Oct; 79(10):573-7. PubMed ID: 15631109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retreatment of chronic pulmonary tuberculosis with regimens including high and low doses of rifampicin in the intermittent phase recent and late results - a controlled comparison study.
    Zierski M; Bek E; Bergson H; Kucharska A; Szelagowicz B
    Bull Int Union Tuberc; 1976; 51(1):121-6. PubMed ID: 1030271
    [No Abstract]   [Full Text] [Related]  

  • 53. [Comparative clinical evaluation of the treatment of chronic pulmonary tuberculosis with various combinations of ethambutol and rifampicin by the daily and intermittent methods].
    Zierski M; Bek E; Bergson H; Kucharska A; Strupczewska-Janusz H
    Pneumonol Pol; 1977 Apr; 45(4):277-90. PubMed ID: 854460
    [No Abstract]   [Full Text] [Related]  

  • 54. Results of treatment with ethambutol and capreomycin in chronic pulmonary tuberculosis.
    Kozakow H; Potworowska M; Janowiec M; Klimkiewicz H; Niemirowski J; Pszonicka A; Pecyna-Sielewicz J; Polaczek E; Rykowska Z; Frenkel A
    Pol Med J; 1970; 9(4):876-85. PubMed ID: 4991068
    [No Abstract]   [Full Text] [Related]  

  • 55. Rifampicin, ethambutol and capreomycin in pulmonary tuberculosis, previously treated with both first and second line drugs: the results of 2 years chemotherapy.
    Aquinas M; Citron KM
    Tubercle; 1972 Sep; 53(3):153-65. PubMed ID: 4116993
    [No Abstract]   [Full Text] [Related]  

  • 56. U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
    Long MW; Snider DE; Farer LS
    Am Rev Respir Dis; 1979 Jun; 119(6):879-94. PubMed ID: 110184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of patients with drug-resistance in economically developed countries.
    Crofton J
    Tubercle; 1969 Mar; 50():Suppl:65-8. PubMed ID: 4319134
    [No Abstract]   [Full Text] [Related]  

  • 58. [Long term results of short course chemotherapy in pulmonary tuberculosis--(1st study):twelve- and eighteen-month chemotherapy with rifampicin-isoniazid and ethambutol].
    Baba H; Schinkai A; Izuchi R; Azuma Y
    Kekkaku; 1986 Jul; 61(7):371-7. PubMed ID: 3761792
    [No Abstract]   [Full Text] [Related]  

  • 59. Ethambutol in the initial treatment of pulmonary tuberculosis. U.S. Public Health Service tuberculosis therapy trials.
    Doster B; Murray FJ; Newman R; Woolpert SF
    Am Rev Respir Dis; 1973 Feb; 107(2):177-90. PubMed ID: 4567069
    [No Abstract]   [Full Text] [Related]  

  • 60. [Therapeutic effect of rifampicin on re-treatment cases of pulmonary tuberculosis. The second study: a study on the combined therapy of rifampicin with ethambutol and pyrazinamide, especially on intermittent therapy].
    Kekkaku; 1972 Dec; 47(12):457-66. PubMed ID: 4652424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.